Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1980 Sep;56(659):663–664. doi: 10.1136/pgmj.56.659.663

Treatment of tardive dyskinesia with choline and tetrabenazine.

A P Snell, M Cleary, M Sambrook
PMCID: PMC2425944  PMID: 7465478

Abstract

A patient with severe tardive dyskinesia due to long-term neuroleptic medication is described. The 2 factors immediately precipitating the onset of the disorder appeared to be the administration of benzhexol hydrochloride and the sudden termination of neuroleptic therapy. the disorder was satisfactorily controlled with choline chloride and a small dose of tetrabenazine. The suggested mechanism of tardive dyskinesia is discussed.

Full text

PDF
663

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chouinard G., De Montigny C., Annable L. Tardive dyskinesia and antiparkinsonian medication. Am J Psychiatry. 1979 Feb;136(2):228–229. doi: 10.1176/ajp.136.2.228. [DOI] [PubMed] [Google Scholar]
  2. Gelenberg A. J., Doller-Wojcik J. C., Growdon J. H. Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study. Am J Psychiatry. 1979 Jun;136(6):772–776. doi: 10.1176/ajp.136.6.772. [DOI] [PubMed] [Google Scholar]
  3. Kazamatsuri H., Chien C., Cole J. O. Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine. Arch Gen Psychiatry. 1972 Jul;27(1):95–99. doi: 10.1001/archpsyc.1972.01750250081011. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES